Full View

The addition of a defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy

B Doran, C Mei, PD Varosy, DP Kao, LA Saxon… - Heart Failure, 2021 - jacc.org
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
被引用次数：15 相关文章

The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy

B Doran, C Mei, PD Varosy, DP Kao, LA Saxon… - 2021 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.

B Doran, C Mei, PD Varosy, DP Kao, LA Saxon… - JACC. Heart …, 2021 - europepmc.org
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
[HTML] sciencedirect.com

[HTML][HTML] The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy

B Doran, C Mei, PD Varosy, DP Kao, LA Saxon… - JACC: Heart Failure, 2021 - Elsevier
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …